Axis-Shield PoC AS
Search within our site
|
|
|
|
|
Afinion HbA1c testPublished in the March 2009 edition of the peer-reviewed journal, “Point of Care” from Baystate Health in Springfield MA, Doctors Arabadjief and Nichols conclude: “The Afinion AS100 Analyzer performed remarkably well and was accurate and precise and compared well with our laboratory Variant II Turbo and current point-of-care DCA2000+ methods. The Afinion AS100 Analyzer was easy to use, and staff noted advantages over the previously employed DCA2000+ system, particularly faster analysis time and easier sample loading. Our point-of-care testing committee was impressed with the Afinion AS100 Analyzer performance and will be recommending this analyzer over existing methods when requests for future point-of-care HbA1c tests are made to the point-of-care testing committee.”Afinion Albumin-Creatinine Ratio (ACR) testIn the same issue of the journal Kvam and colleagues report on the development and excellent performance of the Afinion assay for Albumin-Creatinine Ratio (ACR), used to identify renal complications in diabetes.Comments from the CEOIan Gilham, Axis-Shield CEO, commented: “We are pleased that Baystate Health was impressed with the Afinion system performance for HbA1c and is now using the product. This report typifies the reaction we have observed in the key American physician’s office market where Afinion sales have been particularly strong. We expect that as use of HbA1c testing becomes more widely adopted as a screening parameter for diabetes in primary care, especially to identify Type 2 disease, demand for Afinion will further increase.”Both articles are available online. Please use the following links: Afinion HbA1c: https://articleworks.cadmus.com/doc/987502 Afinion ACR: https://articleworks.cadmus.com/doc/987506 No documents found |
|
|
|
|
|
